Divisions / Investment, Funds & Capital Markets Intelligence / Identity decision · Identity & Source Map
Identity decision

Identity decision · Identity & Source Map

Are we examining the correct legal person, asset or claimed system?

Request written scopeExplore division

The buyer’s decision

Buyer: Funds, family offices, investor-relations teams and external research desks. Decision trigger: Disclosure, fundraise, thesis challenge or material company event.

Defined unit: One main entity or asset and up to four related names, owners, locations, records or aliases.

Research emphasis: Map assertions to dated primary filings, reconcile changes and identify unsupported assumptions.. Records prioritised include SEC filing, public fund report, issuer disclosure.

Exactly what is investigated

  • Confirm exact subject, legal identity and the limited research period
  • Recover the agreed original records and record publication, effective and collection dates
  • Which dated original SEC filing most directly proves the key assertion concerning identity & source map?
  • Could unattributed market claim alter the proposed decision, and which record would disprove it?
  • Test adverse or alternative evidence and distinguish absence of evidence from a negative finding
  • Construct a traceable filing change comparison for this decision
  • Record the specific unavailable evidence and clarify what would change the conclusion
Are we examining the correct legal person, asset or claimed system?

Deliverable and quality control

  • Entity or asset-resolution table, link-confidence explanation and original source chain.
  • filing change comparison using traceable sources
  • Dated and classified findings: supported, contradicted, unresolved or out of scope
  • Human review of source-to-claim traceability and privacy considerations
  • Concisely stated reliance limitations and decision-owner questions

Boundary, cost and acceptance

Commercial rule: Fixed scope and fixed fee agreed in writing, with human acceptance before work begins. A fee amount is not yet approved for publication. No automatic checkout, blanket monitoring commitment, performance guarantee or prepaid credits.

  • No securities recommendations, investment advice or custody.
  • Unlimited records, new jurisdictions, third-party licensed datasets and urgent handling unless contracted
  • Final legal, accounting, medical, security, engineering, valuation or regulated sign-off

For a faster decision, commission the narrowest product that can resolve the immediate evidence question. Larger dossiers are optional and should follow a documented need.

Evidence starting points and what they do not prove

These databases and materials are starting points only. We do not claim that a named buyer, project, company or occurrence has been verified on this page.

What the buyer will receive

Defined evidence, not an unlimited research engagement

Decision-specific checks

  • Does a material investment assertion reconcile with primary disclosures?
  • Independent contrary-source check and named source version/date
  • Explicit not-observed / outside-mandate decision

What to provide

  • Exact subject identifier and jurisdiction
  • Decision date, quoted claim or document
  • Permitted supporting evidence and known contrary claims

Illustrative delivery components

Identity and original-record crosswalk and a source index stating record ID, issuer, effective date, read date and unresolved matters.

Professional reliance limit

No securities recommendations, investment advice or custody.

Illustrative specification only. No factual conclusion or cleared buyer has been represented. Written scope, fee and researcher acceptance are required.

Compare all eight first-purchase options

Evidence before commitment · clearly bounded

A specific answer for a specific decision

Which entity is issuer, adviser, manager and fund vehicle?

What the review checks

  • Record the precise named subject, stable identifier, period and claim being tested.
  • Recover or request form adv/registration entries for relevant adviser subjects and distinguish the original issuer from a vendor-generated summary.
  • Test the adverse possibility that aUM or performance asserted from unaudited marketing charts.
  • State what cannot be established, rather than quietly converting a failed search into an exculpatory finding.
  • Obtain independent human source traceability review and identify the client professional responsible for final reliance.

What you supply

  • Named company or matter, relevant legal entity identifiers, jurisdiction and decision date.
  • Up to the stated cap of quoted claims and original client-held documents available lawfully.
  • Known alternatives, exculpatory evidence and material contrary accounts.
  • Written approval of bounded deliverable, reuse/reliance limits, any paid-source costs and a human reviewer.

A human-reviewed source and contradiction assessment. No general AI answer is accepted as independent evidence. Scope, actual source availability, exclusions, fixed fee and delivery date are agreed in writing before work begins.

Download illustrative PDF: Entity resolution

This specimen describes the method and possible deliverables. It is not a completed client investigation and contains no case findings.

v234